Brussels, 08/01/2013 (Agence Europe) - On 3 January, Michèle Rivasi, the vice-chair of the Greens-EFA Group at the European Parliament, questioned the European Medicines Agency (EMA) on risks of veinous thrombosis complications from the third and fourth generation of contraceptive pills, in response to a complaint filed by France against the pharmaceutical group Bayer.
On 14 December, a young woman lodged a complaint against Bayer as she considered that the third generation pill that she...